HUP0303154A2 - Az oxkarbazepin új kristályformái, és az előállításukra szolgáló eljárások - Google Patents

Az oxkarbazepin új kristályformái, és az előállításukra szolgáló eljárások

Info

Publication number
HUP0303154A2
HUP0303154A2 HU0303154A HUP0303154A HUP0303154A2 HU P0303154 A2 HUP0303154 A2 HU P0303154A2 HU 0303154 A HU0303154 A HU 0303154A HU P0303154 A HUP0303154 A HU P0303154A HU P0303154 A2 HUP0303154 A2 HU P0303154A2
Authority
HU
Hungary
Prior art keywords
oxcarbazepine
processes
crystal forms
preparation
new crystal
Prior art date
Application number
HU0303154A
Other languages
English (en)
Inventor
Judith Aronhime
Yana Berkovich
Ben-Zion Dolitzky
Nissim Garth
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of HUP0303154A2 publication Critical patent/HUP0303154A2/hu
Publication of HUP0303154A3 publication Critical patent/HUP0303154A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

A találmány tárgya az oxkarbazepin új kristályformái, pontosabban a B,C, D, E módosulatok, valamint az ezek előállítására és egymássá valóátalakítására szolgáló eljárások. Ó
HU0303154A 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation HUP0303154A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12
PCT/US2002/004065 WO2002064557A2 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Publications (2)

Publication Number Publication Date
HUP0303154A2 true HUP0303154A2 (hu) 2004-01-28
HUP0303154A3 HUP0303154A3 (en) 2009-08-28

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303154A HUP0303154A3 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Country Status (11)

Country Link
US (1) US7183272B2 (hu)
EP (1) EP1368322A4 (hu)
JP (1) JP2004526706A (hu)
AU (1) AU2002250057A1 (hu)
CA (1) CA2437402A1 (hu)
DE (1) DE02718948T1 (hu)
ES (1) ES2211373T1 (hu)
HU (1) HUP0303154A3 (hu)
IL (1) IL157351A0 (hu)
TR (1) TR200400313T3 (hu)
WO (1) WO2002064557A2 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106414A2 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
JP2009516655A (ja) * 2005-11-22 2009-04-23 テバ ファーマシューティカル インダストリーズ リミティド シナカルセット塩酸塩の結晶形フォーム（Ｆｏｒｍ）、およびそれらの調製方法
PL2004646T3 (pl) 2006-04-05 2016-12-30 Chlorowodorek 8-[{l-(3,5-bis(trifluorometylo)fenylo)-etoksy}-metylol-8-fenylo-1,7-diaza-spiro[4.5]dekan-2-onu i sposób jego otrzymywania
CN101489560B (zh) 2006-04-26 2015-11-25 苏佩努斯制药公司 具有s形释放曲线的奥卡西平控释制剂
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
JP5860399B2 (ja) * 2009-08-14 2016-02-16 オプコ ヘルス， インコーポレイテッド ニューロキニン−１アンタゴニストの静脈内用製剤
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
CA3224977A1 (en) 2018-09-28 2020-04-02 Griffith University Agents and methods for modulating pathogen activity using ligands of complement receptor 3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
WO2003106414A2 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide

Also Published As

Publication number Publication date
US7183272B2 (en) 2007-02-27
EP1368322A4 (en) 2004-03-17
EP1368322A2 (en) 2003-12-10
ES2211373T1 (es) 2004-07-16
IL157351A0 (en) 2004-02-19
TR200400313T3 (tr) 2004-04-21
WO2002064557A9 (en) 2002-11-28
WO2002064557A2 (en) 2002-08-22
CA2437402A1 (en) 2002-08-22
AU2002250057A1 (en) 2002-08-28
US20030004154A1 (en) 2003-01-02
HUP0303154A3 (en) 2009-08-28
JP2004526706A (ja) 2004-09-02
DE02718948T1 (de) 2004-07-08
WO2002064557A3 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
HUP0400149A2 (hu) Új fertőtlenítőszerek
NO20011666D0 (no) Fremgangsmåte for produksjon av fiber som har funksjonelt mineralpulver og fiber produsert derav
HUP0402485A2 (hu) A clopidogrel hidrogénszulfát polimorf módosulatai
HUP0303996A2 (hu) Vakcinakészítmények
HUP0303143A2 (hu) A VII-es faktor és a IX-es faktor polipeptidek kombinált alkalmazása
HUP0302874A2 (hu) Eljárás risperidon előállítására
BR0311645A (pt) Isomalte de galactosila - procedimento para sua produção e emprego
HUP0402029A2 (hu) Peptidalapú multimer célzott kontrasztanyagok
HUP0203601A2 (hu) Mono-amino-oxidáz inhibitorok alkalmazása elhízás kezelésére szolgáló gyógyszerek előállítására
GB2446084A (en) Synthesis of four color 3-o-allyl modified photocleavable fluorescent nucleotides and related methods
HUP0301802A2 (hu) Eljárás carvedilol elżállítására, kristályos carvedilol, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
HUP0303154A2 (hu) Az oxkarbazepin új kristályformái, és az előállításukra szolgáló eljárások
HUP0402043A2 (hu) Rimonabant polimorf formája, eljárás ezen forma előállítására és ilyen polimorf formát tartalmazó gyógyászati készítmények
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
AU2002358667A1 (en) Scented polymer capsules and the production thereof
HUP0401163A2 (hu) Lerkanidipin-hidroklorid új kristályos poliform formái, eljárás ezek előállítására és a kristályos formákat tartalmazó gyógyászati készítmények
IS7239A (is) Aðferð til framleiðslu á essítalóprami
WO2003082895A3 (en) Process to prepare eplerenone
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
HK1117354A1 (en) Jewellery ring and method for the production thereof
EG23204A (en) Process for the production of quinazolines.
IT1317722B1 (it) Procedimento per la produzione di gas di sintesi.
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees